NSD3 and cancer: Given the importance and the prevalence of NSD3 amplifications across several types of cancer, a combination of whole genome sequencing, isoform specific pharmacological targeting, and the study of the interactome of NSD3 will help to understand the altered expression and contribution of both isoforms of NSD3 in cancer.